|
ZNF711 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.533600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.755600E-01 |
| Normal-vs-Stage2 |
8.303800E-01 |
| Normal-vs-Stage3 |
2.162500E-02 |
| Normal-vs-Stage4 |
4.214600E-04 |
| Stage1-vs-Stage2 |
8.290200E-01 |
| Stage1-vs-Stage3 |
8.904300E-02 |
| Stage1-vs-Stage4 |
5.045600E-04 |
| Stage2-vs-Stage3 |
3.331800E-01 |
| Stage2-vs-Stage4 |
4.430300E-02 |
| Stage3-vs-Stage4 |
1.019550E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.910400E-01 |
| Normal-vs-AfricanAmerican |
8.453600E-01 |
| Normal-vs-Asian |
1.373820E-01 |
| Caucasian-vs-AfricanAmerican |
4.991800E-01 |
| Caucasian-vs-Asian |
5.424800E-01 |
| AfricanAmerican-vs-Asian |
1.413220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.392200E-01 |
| Normal-vs-Female |
9.522000E-01 |
| Male-vs-Female |
2.293400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.432850E-01 |
| Normal-vs-Extreme_Weight |
1.781640E-01 |
| Normal-vs-Obese |
8.732400E-01 |
| Normal-vs-Extreme_Obese |
2.371200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.160000E-01 |
| Normal_Weight-vs-Obese |
2.199800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.837400E-01 |
| Extreme_Weight-vs-Obese |
2.870200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.858200E-01 |
| Obese-vs-Extreme_Obese |
4.771600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.799200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.344600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.544380E-01 |
| Normal-vs-Age(81-100Yrs) |
3.257500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.915200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.512800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.837600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.397430E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.694300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.546200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.786990E-01 |
| Normal-VS-Type2 PRCC |
4.9178999983468E-08 |
| Normal-VS-KIRP CIMP |
1.216340E-03 |
| Normal-VS-Unclassified PRCC |
9.831500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.16573417585641E-14 |
| Type1 PRCC-VS-KIRP CIMP |
5.57709999999823E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
4.180800E-03 |
| Type2 PRCC-VS-KIRP CIMP |
8.878000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.239590E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.221350E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.070500E-02 |
| Normal-vs-N1 |
2.429600E-02 |
| Normal-vs-N2 |
4.552400E-02 |
| N0-vs-N1 |
6.792800E-01 |
| N0-vs-N2 |
3.868400E-01 |
| N1-vs-N2 |
4.467800E-01 |
|
|
